11-694804-C-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_021008.4(DEAF1):c.244G>A(p.Ala82Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000187 in 1,409,268 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_021008.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DEAF1 | NM_021008.4 | c.244G>A | p.Ala82Thr | missense_variant | 1/12 | ENST00000382409.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DEAF1 | ENST00000382409.4 | c.244G>A | p.Ala82Thr | missense_variant | 1/12 | 1 | NM_021008.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000924 AC: 14AN: 151438Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000163 AC: 1AN: 61440Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 35958
GnomAD4 exome AF: 0.000198 AC: 249AN: 1257830Hom.: 0 Cov.: 32 AF XY: 0.000194 AC XY: 120AN XY: 617628
GnomAD4 genome AF: 0.0000924 AC: 14AN: 151438Hom.: 0 Cov.: 32 AF XY: 0.000122 AC XY: 9AN XY: 73878
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 30, 2023 | - - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 30, 2022 | Unlikely to be causative of Vulto-van Silfout-de Vries syndrome (AD) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at